Maria Di Gregorio

Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy

Simona Sacco, Stefano Ricci, Raffaele Ornello et al. · Stroke · 2020 · 74 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

Luca Prosperini, Pietro Annovazzi, Laura Boffa et al. · Journal of Neurology · 2018 · 54 citations

Life Sciences, Neurology, Pharmacotherapy +15

Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study

Maria Petracca, Serena Ruggieri, Elena Barbuti et al. · Neurology and Therapy · 2022 · 43 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +14

Computerized EEG topography findings in schizophrenic patients before and after haloperidol treatment

D. Kemali, Silvana Galderisi, M. Maj et al. · International Journal of Psychophysiology · 1992 · 39 citations

Medicine, Neuroscience, Psychiatry +11

Hippocampal neuroplasticity and inflammation: relevance for multiple sclerosis

Andrea Mancini, Lorenzo Gaetani, Maria Di Gregorio et al. · Multiple Sclerosis and Demyelinating Disorders · 2017 · 30 citations · Full text

Life Sciences, Neurology, Neuroscience +17